Q1 2019 Holdings
Filed 2019-05-14 | 194 holdings | $224.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $74.3M | 314,278 | 33.2% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $25.8M | 320,213 | 11.5% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $19.7M | 222,086 | 8.8% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $18.2M | 473,619 | 8.1% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $12.5M | 94,889 | 5.6% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $12.5M | 133,458 | 5.6% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $8.0M | 28,278 | 3.6% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $7.2M | 61,360 | 3.2% |
| Centene Corporation(CNC) | Common | 15135B101 | $6.8M | 128,295 | 3.0% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $6.2M | 91,776 | 2.8% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $5.1M | 173,155 | 2.3% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $4.3M | 315,162 | 1.9% |
| Bausch Health Companies Inc.(BHC) | Common | 071734107 | $4.2M | 168,812 | 1.9% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $3.5M | 28,381 | 1.6% |
| Cellectis SA(CLLS) | Sponsored ADR | 15117K103 | $3.2M | 173,035 | 1.4% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $2.8M | 104,714 | 1.3% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $1.8M | 639,370 | 0.8% |
| Akebia Therapeutics, Inc.(AKBA) | Common | 00972D105 | $1.8M | 213,942 | 0.8% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $1.5M | 10,640 | 0.7% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $983.0K | 228,496 | 0.4% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $761.0K | 203,935 | 0.3% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $563.0K | 30,700 | 0.3% |
| Celgene Corporation(CELG) | Common | 151020104 | $139.0K | 1,473,710 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $133.8K | 704,383 | 0.1% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $125.5K | 897,990 | 0.1% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $113.7K | 1,749,388 | 0.1% |
| Pfizer Inc.(PFE) | Common | 717081103 | $87.9K | 2,070,765 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $82.6K | 993,083 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $81.6K | 443,712 | 0.0% |
| Unitedhealth Group Incorporated(UNH) | Common | 91324P102 | $80.1K | 324,133 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $73.8K | 237,514 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $58.1K | 141,532 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $50.8K | 375,705 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $45.5K | 529,133 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $44.8K | 492,002 | 0.0% |
| Anthem, Inc.(ELV) | Common | 036752103 | $40.6K | 141,358 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $39.1K | 142,743 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $38.3K | 295,320 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $36.5K | 457,048 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $35.2K | 738,044 | 0.0% |
| Celldex Therapeutics, Inc.(CLDX) | Common | 15117B202 | $35.0K | 7,053 | 0.0% |
| Allergan plc | Shares | G0177J108 | $28.3K | 193,263 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $27.3K | 506,364 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $26.7K | 943,152 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $26.6K | 276,847 | 0.0% |
| Zoetis Inc.(ZTS) | Class A | 98978V103 | $25.9K | 257,001 | 0.0% |
| Stryker Corporation(SYK) | Common | 863667101 | $24.3K | 123,050 | 0.0% |
| Intuitive Surgical, Inc.(ISRG) | Common | 46120E602 | $23.0K | 40,281 | 0.0% |
| Seattle Genetics, Inc. | Common | 812578102 | $21.2K | 289,925 | 0.0% |
| Danaher Corporation(DHR) | Common | 235851102 | $21.0K | 158,931 | 0.0% |